PCRX R&D Expenses
Pacira Biosciences Inc · R&D Expenses
PCRX R&D Expenses
Latest reported$121.73Mperiod ending
PCRX TTM R&D Expenses ($18.63M → $121.73M)
TTM R&D Expenses
High-resolution chart · PNG
PCRX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 121,734,000 | |
| 119,691,000 | |
| 116,961,000 | |
| 103,405,000 | |
| 96,543,000 | |
| 88,681,000 | |
| 81,577,000 | |
| 77,143,000 | |
| 78,869,000 | |
| 77,355,000 | |
| 76,257,000 | |
| 74,299,000 | |
| 72,874,000 | |
| 80,332,000 | |
| 84,797,000 | |
| 82,806,000 | |
| 74,979,000 | |
| 61,270,000 | |
| 55,544,000 | |
| 55,361,000 | |
| 58,434,000 | |
| 59,481,000 | |
| 59,421,000 | |
| 63,743,000 | |
| 69,347,000 | |
| 73,554,000 | |
| 72,119,000 | |
| 66,640,000 | |
| 61,282,000 | |
| 55,694,000 | |
| 55,688,000 | |
| 51,542,000 | |
| 48,420,000 | |
| 55,037,000 | |
| 57,291,000 | |
| 64,332,000 | |
| 62,311,000 | |
| 52,817,000 | |
| 45,678,000 | |
| 41,762,000 | |
| 37,901,000 | |
| 32,188,000 | |
| 28,662,000 | |
| 19,395,000 | |
| 17,927,000 | |
| 19,494,000 | |
| 18,731,000 | |
| 19,681,000 | |
| 21,218,000 | |
| 20,859,000 | |
| 21,560,000 | |
| 19,968,000 | |
| 17,533,000 | |
| 14,548,000 | |
| 9,937,000 | |
| 9,329,000 | |
| 10,146,000 | |
| 12,655,000 | |
| 14,874,000 | |
| 15,912,000 | |
| 17,284,000 | |
| 17,499,000 | |
| 18,628,000 | |
| 22,470,000 | |
| 22,324,000 |